{"id":"https://genegraph.clinicalgenome.org/r/4742980c-ffb7-4b3d-9a79-1ea85f27a6a7v1.0","type":"EvidenceStrengthAssertion","dc:description":"*ALDOB* was first reported in relation to autosomal recessive hereditary fructose intolerance in 1988 (Cross et al., PMID: 3383242). Thirteen variants (missense, in-frame indel, nonsense, frameshift, splice), that have been reported in twelve probands in five publications (PMIDs: 3383242, 8071980, 1967768, 18541450, 25595217) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by a knockout mouse model (PMID: 25637246). In summary, there is definitive evidence supporting the relationship between *ALDOB* and autosomal recessive hereditary fructose intolerance. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. UNC and Myriad Women’s Health biocurators contributed to this curation. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date September 4, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4742980c-ffb7-4b3d-9a79-1ea85f27a6a7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7","calculatedEvidenceStrength":"Definitive","contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10084","role":"SecondaryContributor"},{"agent":"https://genegraph.clinicalgenome.org/agent/10018","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-09-04T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-09-04T16:20:00.955Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/464b7c55-bcae-4b57-a6f1-c19f42a370c9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/619aab60-5411-4910-baaf-018dad1f9c80","type":"Finding","dc:description":"KO mice had similar aldolase B test results to humans with HFI and ALDOB mutations. When exposed to fructose, the KO mice did not live as long and did not grow well, which is also similar to humans. On a fructose-free diet, the mice were similar to WT in size and mortality. KO mouse liver histology post-fructose removal was similar to humans who have undergone treatment for HFI.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25637246","rdfs:label":"Oppelt Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4aebffe7-b290-428a-8389-e9ddaccc4fdf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05d25138-fd8b-4412-801b-edb5ab4839f2","type":"EvidenceLine","dc:description":"Reduced due to lack of specific phenotype information.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05d25138-fd8b-4412-801b-edb5ab4839f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8071980","allele":{"id":"https://genegraph.clinicalgenome.org/r/60122f34-339b-4ecc-a595-a2c735728b87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.10C>T (p.Arg4Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/471"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4aebffe7-b290-428a-8389-e9ddaccc4fdf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8071980","rdfs:label":"Ali Turkish Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/60122f34-339b-4ecc-a595-a2c735728b87"},"detectionMethod":"PCR + direct sequencing of ALDOB first of founder variants A149P, A174D, and N334K then sequencing of whole gene when only 1 variant or no variants were identified. Segregation confirmed by ARMS.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"none specified, proband was diagnosed based on clinical history of sugar intolerance","previousTesting":false,"previousTestingDescription":"N/A","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/05d25138-fd8b-4412-801b-edb5ab4839f2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a624707e-95b6-4c17-9f98-b05075ab23e0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/312b5c10-adc9-4f17-9bd4-d8472d059e39","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/312b5c10-adc9-4f17-9bd4-d8472d059e39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25595217","allele":{"id":"https://genegraph.clinicalgenome.org/r/eccd0c6e-4f26-4a6c-a3da-4d52e2adc9fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.324+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/218380"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a624707e-95b6-4c17-9f98-b05075ab23e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25595217","rdfs:label":"Bijarnia-Mahay Proband 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/eccd0c6e-4f26-4a6c-a3da-4d52e2adc9fd"},"detectionMethod":"PCR + direct sequencing of all 9 exons of ALDOB","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001508","obo:HP_0002240","obo:HP_0002014","obo:HP_0001263","obo:HP_0001397","obo:HP_0003160"],"previousTesting":false,"previousTestingDescription":"N/A","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/312b5c10-adc9-4f17-9bd4-d8472d059e39_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/434b2f05-d2ef-406a-b4b3-47f3b23df4a1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f9769ca-a5a1-4b68-b58d-2a3e83fef38a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f9769ca-a5a1-4b68-b58d-2a3e83fef38a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339810"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/72fd9b08-7143-4b14-b7c1-c1d2aacc02cc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72fd9b08-7143-4b14-b7c1-c1d2aacc02cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/46a8b764-60da-4274-a999-4f5514a63845","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.444G>A (p.Trp148Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16041285"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/434b2f05-d2ef-406a-b4b3-47f3b23df4a1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"},{"id":"https://genegraph.clinicalgenome.org/r/46a8b764-60da-4274-a999-4f5514a63845"}],"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002240","obo:HP_0002013","obo:HP_0002910"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/72fd9b08-7143-4b14-b7c1-c1d2aacc02cc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4f9769ca-a5a1-4b68-b58d-2a3e83fef38a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/8c0b13fa-56a2-4967-b6ca-9a3bf92bf2be_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae5c974f-43de-4deb-8cb9-24eb5b1f6dec","type":"EvidenceLine","dc:description":"Reduced score due to lack of specific phenotype information.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae5c974f-43de-4deb-8cb9-24eb5b1f6dec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1967768","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcd567a8-7718-4f45-930c-a068d9b5b83c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.865del (p.Leu289PhefsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/218381"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8c0b13fa-56a2-4967-b6ca-9a3bf92bf2be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1967768","rdfs:label":"Cross Sicily Proband 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcd567a8-7718-4f45-930c-a068d9b5b83c"},"detectionMethod":"PCR + direct sequencing of ALDOB","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"None specified, paper notes that probands were diagnosed via clinical history and fructose intolerance test results.","previousTesting":false,"previousTestingDescription":"N/A","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae5c974f-43de-4deb-8cb9-24eb5b1f6dec_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/aaa3fd99-aee3-4c54-9d62-604d2539ef81_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/749a6a3c-b5e5-4b04-9dc9-ff4d06b2bd7b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/749a6a3c-b5e5-4b04-9dc9-ff4d06b2bd7b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c07e1c3-35fc-4b92-bc3e-2d8a26b428e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.112+1G>A (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA374266082"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/387d4c82-8d31-4961-967a-c67997f26919","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/387d4c82-8d31-4961-967a-c67997f26919_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aaa3fd99-aee3-4c54-9d62-604d2539ef81","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 6","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5c07e1c3-35fc-4b92-bc3e-2d8a26b428e0"},{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"}],"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"Familial history of HFI, brother died of liver failure after sucrose infusion before diagnosis of HFI was made","previousTesting":true,"previousTestingDescription":"Hepatic aldolase B testing","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/387d4c82-8d31-4961-967a-c67997f26919_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/749a6a3c-b5e5-4b04-9dc9-ff4d06b2bd7b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/6ebdff1b-243b-46d3-a81d-f3674242cb1a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dbccfed-cf8a-4e7c-87a0-9e1be1fbaf39","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dbccfed-cf8a-4e7c-87a0-9e1be1fbaf39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/9876c9b5-6b63-41d4-9a01-a10c28a6ce86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.932T>C (p.Leu311Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA374264322"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/6ebdff1b-243b-46d3-a81d-f3674242cb1a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9876c9b5-6b63-41d4-9a01-a10c28a6ce86"},"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","firstTestingMethod":"PCR","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0002240","obo:HP_0001943","obo:HP_0002910"],"previousTesting":true,"previousTestingDescription":"Fructose load","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1dbccfed-cf8a-4e7c-87a0-9e1be1fbaf39_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/12569f8b-16f6-49a6-9f0d-943751806c2a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d87e46f-9632-4b93-af89-1bd6da10122e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d87e46f-9632-4b93-af89-1bd6da10122e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a78ff7d9-461f-45d0-9c01-e8ff5159c72b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a78ff7d9-461f-45d0-9c01-e8ff5159c72b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb4f1706-541d-43ef-9202-414bfc5b0569","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.146del (p.Val49GlyfsTer29)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499219521"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/12569f8b-16f6-49a6-9f0d-943751806c2a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 5","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":25,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/cb4f1706-541d-43ef-9202-414bfc5b0569"},{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"}],"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","firstTestingMethod":"PCR","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0002240","obo:HP_0002013"],"previousTesting":true,"previousTestingDescription":"Fructose load","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0d87e46f-9632-4b93-af89-1bd6da10122e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a78ff7d9-461f-45d0-9c01-e8ff5159c72b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/aa68de86-846d-43f5-b134-e21dfd89cf22_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa55da04-88f0-4714-af89-adf41b5e9d33","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa55da04-88f0-4714-af89-adf41b5e9d33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/b70f33b2-c4f4-4085-882b-61804bee946f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.683_688dup (p.Leu229_Lys230insMetLeu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA590045512"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/801b0902-e0ab-4ae5-b87a-4c56e5526428","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/801b0902-e0ab-4ae5-b87a-4c56e5526428_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9e64f37-1169-4759-a8c1-13102c970c70","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.1005C>G (p.Asn335Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339812"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aa68de86-846d-43f5-b134-e21dfd89cf22","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 7","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b70f33b2-c4f4-4085-882b-61804bee946f"},{"id":"https://genegraph.clinicalgenome.org/r/b9e64f37-1169-4759-a8c1-13102c970c70"}],"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","firstTestingMethod":"PCR","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0002240","obo:HP_0002910","obo:HP_0001943","obo:HP_0002014"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/fa55da04-88f0-4714-af89-adf41b5e9d33_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/801b0902-e0ab-4ae5-b87a-4c56e5526428_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/cfa50e14-afd0-4685-9f33-ebab10e8119c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf18fd4-2baf-437c-a959-b766bb49541d","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf18fd4-2baf-437c-a959-b766bb49541d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3383242","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/cfa50e14-afd0-4685-9f33-ebab10e8119c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3383242","rdfs:label":"Cross 1988 Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6e3ba6-0375-487b-ae75-01075cbae329"},"detectionMethod":"Sanger sequencing of exon 5","firstTestingMethod":"Restriction digest","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0002027","obo:HP_0002013","obo:HP_0001259"],"previousTesting":true,"previousTestingDescription":"PMID: 6348085 - fructose-1-phosphate aldolase activity reduced to 2-6% of mean control values.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9bf18fd4-2baf-437c-a959-b766bb49541d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9997dba9-812f-4480-98d8-d0b3a050dbc7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4237ddec-fef0-4225-b22f-92366293b51b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8071980","rdfs:label":"Turkish Family","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/4237ddec-fef0-4225-b22f-92366293b51b","type":"Family","rdfs:label":"Turkish Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4aebffe7-b290-428a-8389-e9ddaccc4fdf"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"none specified, proband was diagnosed based on clinical history of sugar intolerance","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4aebffe7-b290-428a-8389-e9ddaccc4fdf"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b3bc2bd3-a60a-4e2a-85ba-1b0995ec97b9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d06fc5fd-a2e7-45f5-8715-f18b0f1a0b20","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d06fc5fd-a2e7-45f5-8715-f18b0f1a0b20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/82eb2963-d991-4101-b97a-31f774c7a7e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.170G>C (p.Arg57Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA374265954"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b3bc2bd3-a60a-4e2a-85ba-1b0995ec97b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/82eb2963-d991-4101-b97a-31f774c7a7e6"},"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0001397","obo:HP_0002013"],"previousTesting":true,"previousTestingDescription":"Fructose load","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d06fc5fd-a2e7-45f5-8715-f18b0f1a0b20_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c7ad43ee-7c61-473c-8fb8-516ff78252eb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a2f73b2-1d86-4797-87ca-e080495db3cd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a2f73b2-1d86-4797-87ca-e080495db3cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/c453a36c-5047-46f4-abba-2540fd4815bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339811"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/24e22ca9-4f08-4d52-ad2a-6b65bb63a19a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24e22ca9-4f08-4d52-ad2a-6b65bb63a19a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","allele":{"id":"https://genegraph.clinicalgenome.org/r/f80cadc0-6830-4ad8-88dc-cebd62ac5b97","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000035.4(ALDOB):c.839C>A (p.Ala280Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA374264515"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c7ad43ee-7c61-473c-8fb8-516ff78252eb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18541450","rdfs:label":"Davit-Spraul Proband 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":31,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f80cadc0-6830-4ad8-88dc-cebd62ac5b97"},{"id":"https://genegraph.clinicalgenome.org/r/c453a36c-5047-46f4-abba-2540fd4815bd"}],"detectionMethod":"We first screened for the 3 most frequent aldolase B gene mutations by PCR-restriction as previously described [8]. Extensive ALDOB gene analyses were performed in patients with only one or no identified alleles by (i) scanning of exons 2–9 and their bound­aries using PCR and sequencing (sequence of primers are given in Table 1), (ii) search for large dele­tion or insertion by long range PCR (LR-PCR) using forward primer exon 2 and reverse primer exon 9.","firstTestingMethod":"PCR","phenotypeFreeText":"aversion to sweet food","phenotypes":["obo:HP_0002013","obo:HP_0100626"],"previousTesting":true,"previousTestingDescription":"Fructose load","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/24e22ca9-4f08-4d52-ad2a-6b65bb63a19a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7a2f73b2-1d86-4797-87ca-e080495db3cd_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d8d0a7fc-7b89-4433-b150-d31d851700be_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c0a06b6-3cc9-40c8-8ee9-e67974d233ef","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c0a06b6-3cc9-40c8-8ee9-e67974d233ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1967768","allele":{"id":"https://genegraph.clinicalgenome.org/r/c453a36c-5047-46f4-abba-2540fd4815bd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d8d0a7fc-7b89-4433-b150-d31d851700be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1967768","rdfs:label":"Cross Sicily Proband 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/c453a36c-5047-46f4-abba-2540fd4815bd"},"detectionMethod":"\tPCR + direct sequencing of ALDOB","firstTestingMethod":"PCR","phenotypeFreeText":"None specified, paper notes that probands were diagnosed via clinical history and fructose intolerance test results.","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8c0a06b6-3cc9-40c8-8ee9-e67974d233ef_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":11517,"specifiedBy":"GeneValidityCriteria11","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/stQiocMsuO4","type":"GeneValidityProposition","disease":"obo:MONDO_0009249","gene":"hgnc:417","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9997dba9-812f-4480-98d8-d0b3a050dbc7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}